Leap Therapeutics (Nasdaq: LPTX), a Cambridge, Massachusetts-based biotechnology company, is going to rebrand itself into ...

Nevadans can now borrow electronic radon monitors from University of Nevada, Reno Extension to quickly test their homes for ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

As of November 12, 2025, ProMIS has fully enrolled Cohorts 1 and 2 and is well into Cohort 3, with complete enrollment ...

Key opportunities in the RNA targeting small molecules therapeutics market include growth in RNA splicing modifications, neurodegenerative diseases, drug discovery, and pharma-biotech sectors.

Cohorts 1 and 2 are fully enrolledPMN310 continues to demonstrate a favorable safety profileOn track to report 6-month interim data in Q2 2026 ...

In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year ...